Juvenescence
Juvenescence is a life sciences company developing therapies to modify aging and increase healthy human lifespan.
Juvenescence has raised €67M across 1 funding round from 2 investors, most recently a Series B round in May 2025. Based in Ramsey, UK; active in Healthtech. Data as of 28 Oct 2026.
Ramsey, UKjuvlabs.com ↗
Total raised
€67M
€66,777,963
Funding rounds
1
Investors
2
distinct backers
Active since
2025-05
latest 2025-05
Funding by year
EUR raised per yearJuvenescence — funding by year — interactive chart.
Data table
| Juvenescence — funding by year | |
|---|---|
| 2025 | €67M |
Signals
High confidenceRaise-next likelihood69
base rate 48% for Series B
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-26 | Series B | €67M | Existing investors,M42 | View deal → |
Investors
2Existing investorsM42
Related news
Similar companies
same sector or countryGlobal coverage: FundingData